Deep Vein Thrombosis (DVT): Symptoms, Diagnosis, and Emergency Treatment

Citable definition: Deep vein thrombosis (DVT) is the formation of a blood clot (thrombus) within a deep vein — most commonly in the legs — that can obstruct blood flow, damage the vein wall, and, if the clot dislodges, cause a life-threatening pulmonary embolism (a clot that travels to and blocks the lungs). Together, DVT and pulmonary embolism constitute venous thromboembolism (VTE), one of the leading causes of preventable hospital mortality worldwide.

What Is Deep Vein Thrombosis?

Deep vein thrombosis occurs when a blood clot forms inside one of the large veins that run through the muscles of the leg, thigh, or pelvis — and, less frequently, in the arms, abdomen, or brain. Unlike superficial veins (the small vessels visible just under the skin), deep veins carry the majority of blood returning to the heart, making a clot in this system potentially dangerous.

The underlying mechanism was described by the 19th-century German physician Rudolf Virchow and remains the foundation of modern DVT science. Virchow’s triad identifies three conditions that promote clot formation:

1. Stasis — sluggish blood flow (e.g., during long-haul flights or bed rest)
2. Endothelial injury — damage to the inner lining of the vein (e.g., after surgery or trauma)
3. Hypercoagulability — an increased tendency of the blood to clot (e.g., inherited disorders, cancer, or certain medications)

VTE (venous thromboembolism) affects an estimated 1–2 people per 1,000 each year in Western populations, with incidence rising sharply after age 40 (Heit JA, Arterioscler Thromb Vasc Biol, 2008; PMID: 18296591). It is the third most common cardiovascular condition after heart attack and stroke.

For a broader overview of vein conditions, visit our vein health section.

Symptoms of DVT

One of the most dangerous aspects of DVT is that it can be entirely silent. Approximately 50% of cases present without classic symptoms. When symptoms do occur, they typically affect one limb and may include:

Common Symptoms (Leg DVT)

• Swelling of the calf, ankle, or entire leg (usually one-sided)
• Pain or tenderness — often described as a cramp, ache, or heaviness, typically in the calf
• Warmth over the affected area
• Skin discoloration — redness or a bluish tinge (cyanosis)
• Distended superficial veins visible under the skin

Warning Signs of Pulmonary Embolism (PE) — Seek Emergency Care Immediately

If the clot breaks free and travels to the lungs, symptoms become acute and life-threatening:

• Sudden shortness of breath
• Sharp chest pain, worsening with deep breathing
• Rapid heart rate (tachycardia)
• Coughing up blood (hemoptysis)
• Fainting or loss of consciousness

If you experience any of these symptoms, call emergency services (112 in Europe, 911 in the US) immediately.

Less Common Forms of DVT

• Upper-extremity DVT (arm veins): accounts for roughly 4–10% of all DVT cases and is increasingly associated with central venous catheters
• Cerebral venous thrombosis (CVT): clotting in the brain’s venous sinuses, presenting with severe headache, visual disturbances, or seizures. A 2026 study of CVT occurring after brain surgery illustrates that this rare but serious condition may require prompt neuroimaging and specialist management (Nunes AJ, Carvalho M, Clin Neurol Neurosurg, 2026; DOI: 10.1016/j.clineuro.2026.109349; PMID: 41713126)
• Mesenteric venous thrombosis: clotting in the veins supplying the intestines, which can present with abdominal pain or, in severe cases, gastrointestinal bleeding. A 2026 case report described hematemesis (vomiting blood) as a presenting sign of mesenteric venous thrombosis, highlighting how atypical DVT presentations can delay diagnosis (Shi C et al., Exp Ther Med, 2026; DOI: 10.3892/etm.2026.13120; PMID: 41858770)

Risk Factors

Understanding your personal risk is essential for prevention. Major risk factors include:

Orthopedic surgery carries particularly high VTE risk. A 2026 study found that inter-atrial wall abnormalities (such as atrial septal defects or patent foramen ovale) were associated with worse same-admission outcomes following total hip arthroplasty, reinforcing the need for comprehensive pre-operative cardiac risk stratification in this population (Zhang BB et al., J Orthop, 2026; DOI: 10.1016/j.jor.2026.03.002; PMID: 41815581).

Diagnosis

No clinical examination alone can reliably confirm or exclude DVT. Diagnosis combines clinical probability scoring, blood tests, and imaging.

Step 1 — Clinical Probability: The Wells Score

The Wells DVT score assigns points for symptoms, signs, and risk factors. A score of 2 or above indicates high probability and prompts immediate imaging. This scoring system is endorsed by both the European Society for Vascular Surgery (ESVS) 2021 Guidelines on Venous Thrombosis [unverified; PMID: 33334670] and the American College of Chest Physicians (ACCP/CHEST) 2021 Antithrombotic Guidelines [unverified; PMID: 34352278].

Step 2 — D-Dimer Blood Test

D-dimer is a protein fragment released when a clot breaks down. A negative D-dimer in a low-probability patient effectively rules out DVT without the need for imaging. However, D-dimer is non-specific — it is elevated in many conditions including pregnancy, infection, and recent surgery — so a positive result always requires imaging confirmation.

Step 3 — Duplex Ultrasound

Compression ultrasonography (pressing the ultrasound probe on the vein to check if it collapses normally) is the gold-standard first-line imaging test. It is non-invasive, radiation-free, and widely available. Sensitivity and specificity exceed 94% for proximal (thigh-level) DVT.

Step 4 — Advanced Imaging (Selected Cases)

• CT venography or MRI venography: used when ultrasound is inconclusive, or for suspected pelvic, abdominal, or upper-extremity DVT
• Venography (contrast dye injected into veins): the historical gold standard, now rarely used due to its invasive nature

Treatment

Treatment aims to: (1) prevent clot extension, (2) prevent pulmonary embolism, (3) reduce the risk of recurrence, and (4) minimize long-term vein damage (post-thrombotic syndrome).

Anticoagulation (Blood-Thinning Medication)

Anticoagulation remains the cornerstone of DVT treatment. Options include:

DOACs have largely replaced warfarin as first-line therapy due to their predictable dosing, fewer drug interactions, and comparable efficacy with a lower risk of intracranial bleeding.

Compression Therapy

Graduated compression stockings (20–30 mmHg or 30–40 mmHg) reduce swelling and may help prevent post-thrombotic syndrome (PTS) — the chronic leg pain, swelling, and skin changes that affect up to 50% of DVT patients according to available data. The ESVS recommends their use in symptomatic proximal DVT [unverified; PMID: 33334670].

Thrombolysis and Interventional Treatment

For extensive, limb-threatening DVT — particularly ilio-femoral DVT (clots extending into the pelvis) — more aggressive options may be considered:

• Catheter-directed thrombolysis (CDT): delivering clot-dissolving drugs (thrombolytics) directly into the clot via a catheter
• Pharmacomechanical thrombectomy: combining mechanical clot removal with thrombolytics
• Surgical thrombectomy: rarely performed, reserved for massive DVT with limb ischemia

These interventional approaches are more common in younger patients with good functional status and low bleeding risk. Consult your vascular specialist to determine whether you are a candidate.

Inferior Vena Cava (IVC) Filter

An IVC filter is a small metal device inserted into the body’s main vein (vena cava) to catch clots before they reach the lungs. It is not a substitute for anticoagulation and is reserved for patients who have an absolute contraindication to blood thinners (e.g., active major bleeding). Available guidelines recommend retrievable filters be removed as soon as anticoagulation becomes safe [unverified; PMID: 33334670, PMID: 34352278].

Prevention

Prevention is especially important for high-risk individuals. Evidence-based strategies include:

In Hospital / After Surgery

• Mechanical prophylaxis: graduated compression stockings and intermittent pneumatic compression (IPC) devices — inflatable sleeves that massage the legs during immobility
• Pharmacological prophylaxis: low-dose LMWH or DOACs prescribed by your surgical team, typically starting within 12–24 hours of surgery

During Long-Distance Travel

• Stay hydrated; avoid alcohol and sedatives
• Perform calf exercises every 30–60 minutes (ankle circles, heel raises)
• Walk the aisle when possible
• Consider below-knee compression stockings (15–20 mmHg) for flights over 4 hours if you have additional risk factors

Daily Lifestyle Measures

• Maintain a healthy weight — obesity doubles VTE risk according to available data
• Stay physically active — regular walking improves venous return
• Avoid prolonged sitting — break up desk work every hour
• Stay well hydrated
• Do not smoke — smoking promotes hypercoagulability and endothelial injury
• Discuss hormonal contraception with your doctor if you have other VTE risk factors

For more actionable tips, explore our prevention section.

When to See a Doctor

Seek urgent medical attention if you have:

• Unexplained swelling in one leg, especially with pain or warmth
• A red, tender cord-like area along a vein
• Sudden shortness of breath or chest pain
• Any combination of the above after recent surgery, hospitalization, or long-haul travel

Schedule a routine appointment if you have:

• A family history of blood clots or a known clotting disorder
• Recurrent unexplained leg swelling
• Questions about DVT risk before long travel, surgery, or starting hormonal therapy

Early diagnosis is critical. Do not attempt to self-diagnose or self-treat. A vascular specialist, hematologist, or internist can assess your individual risk and recommend the appropriate course of action.

Also available in French

Sources

1. Heit JA. “The epidemiology of venous thromboembolism in the community.” Arterioscler Thromb Vasc Biol. 2008;28(3):370–372. PMID: 18296591. DOI: 10.1161/ATVBAHA.108.162545

2. Nunes AJ, Carvalho M. “Cerebral venous thrombosis after brain surgery.” Clin Neurol Neurosurg. 2026 May;264:109349. PMID: 41713126. DOI: 10.1016/j.clineuro.2026.109349

3. Shi C, Li Z, Pan L, Song B. “Hematemesis resulting from mesenteric venous thrombosis: A case report.” Exp Ther Med. 2026 May;31(5):125. PMID: 41858770. DOI: 10.3892/etm.2026.13120

4. Zhang BB, Uddin AA, Mai DH, Buksbaum J, Lee M, Naziri Q. “Inter-atrial wall abnormality is associated with adverse same-admission outcomes following total hip arthroplasty.” J Orthop. 2026 May;75:317–321. PMID: 41815581. DOI: 10.1016/j.jor.2026.03.002

5. Ortel TL et al. “American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.” Blood Adv. 2020;4(19):4693–4738. PMID: 33007077. DOI: 10.1182/bloodadvances.2020001830 [Note: abstract not independently verified in this review]

6. Kakkos SK et al. “European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.” Eur J Vasc Endovasc Surg. 2021;61(1):9–82. PMID: 33334670. DOI: 10.1016/j.ejvs.2020.09.023 [Note: abstract not independently verified in this review]

7. Stevens SM et al. “Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.” Chest. 2021;160(6):e545–e608. PMID: 34352278. DOI: 10.1016/j.chest.2021.07.055 [Note: abstract not independently verified in this review]

Medical Disclaimer: This article is produced by the Petit Veinard editorial board for informational and educational purposes only. It does not constitute medical advice, diagnosis, or a treatment recommendation. All medical decisions, including the initiation, modification, or discontinuation of any therapy, must be made in consultation with a qualified physician or vascular specialist. If you believe you are experiencing symptoms of deep vein thrombosis or pulmonary embolism, seek emergency medical care immediately. Petit Veinard (petitveinard.com) is an independent publication and has no commercial relationship with any pharmaceutical company or medical device manufacturer.